Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Driver and Vehicle Licensing Agency
The treatment Understanding the treatment Active Ingredient: Tirzepatide Zepbound are brand-name formulations of tirzepatide, a once-weekly injectable that activates both GIP and GLP-1 receptors
The pilot phase demonstrated a 7.4 mmHg between group difference in 24-h SBP [149]
Warning Signs to Watch For If you do choose to drink while on GLP-1 therapy, Agrawal advises stopping and seeking medical advice if you experience: Dizziness, confusion, sweating, shakiness, or slurred speech Severe or persistent nausea and vomiting Abdominal pain that could suggest pancreatitis Feeling unusually impaired despite drinking a small amount Worsened hangovers compared to your normal experience Trouble thinking clearly or coordinating movements Any of these symptoms are a reason to stop drinking and seek medical guidance, Agrawal says
